Skip to content
DataLookout
Start free
Menu

TAILOR-DAPTNCT05732701

Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 11 months later.

See at-risk trials from Insel Gruppe AG, University Hospital Bern

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2027 to Dec 2029 Show 5 more changesShow less
    • Study completion pushed from Dec 2028 to Dec 2030
    • Study sites: 3 to 4
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints revised (19)
    • Study description expanded, about 6 words
  2. Primary completion date: Mar 2025 to Dec 2027
    • Study sites: 2 to 3
    • Study completion date: Dec 2026 to Dec 2028
    v7
  3. Study sites: 1 to 2v6
  4. Study completion date: Apr 2026 to Dec 2026v4 Show 4 more changesShow less
    • Secondary endpoints: 18 to 19
    • Site contact updated
    • Eligibility criteria expanded, about 1 word
    • Study description expanded, about 5 words
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2023 to Jun 27, 2023
    • Site details revised
    v3
  6. Secondary endpoints revised (18)v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Net adverse clinical events (NACE)
Timeframe: 1 year

Secondary (18)

Major adverse cardiovascular events (MACE)
Major or clinically relevant non-major bleeding
Major bleeding
Any non-access site related Bleeding Academic Research Consortium (BARC) bleeding
All-cause death
Show 13 moreShow less
Cardiovascular death
Myocardial infarction
Spontaneous myocardial infarction
Target lesion failure
Target vessel revascularization
Target vessel myocardial infarction
Target lesion revascularization
Non-target vessel revascularization
Any revascularization
Definite stent thrombosis
Stroke
Transient ischemic attack
Adherence to DAPT

Arms and interventions

InterventionExperimental

Algorithm-guided DAPT duration

StandardActive comparator

Standard-of-care DAPT duration

Other: Algorithm-guided DAPT duration, Standard-of-care DAPT duration

Sites

4 sites in 3 countries

Switzerland 2, Bosnia and Herzegovina 1, Italy 1